相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identifying factors that impact survival among women with inflammatory breast cancer
S. Dawood et al.
ANNALS OF ONCOLOGY (2012)
MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression
Xiang-yu Zhong et al.
GENE (2012)
MicroRNA Profiling Differentiates Colorectal Cancer According to KRAS Status
Neda Mosakhani et al.
GENES CHROMOSOMES & CANCER (2012)
Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: Evidence that PKCι/λ overexpression is an independent prognostic factor
Khalid Dafaallah Awadelkarim et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells
Yan Zhang et al.
MOLECULAR CANCER RESEARCH (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S. Dawood et al.
ANNALS OF ONCOLOGY (2011)
MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer
Jun Hao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
Takayuki Iwamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
Wei Shi et al.
CANCER RESEARCH (2011)
A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Xiaogang Tan et al.
CLINICAL CANCER RESEARCH (2011)
Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
Hue-Kian Oh et al.
CLINICAL CANCER RESEARCH (2011)
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
C. Giordano et al.
ONCOGENE (2011)
High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes
Ismahane Bekhouche et al.
PLOS ONE (2011)
Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs
Dario Greco et al.
PLOS ONE (2011)
MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer
Cathy A. Andorfer et al.
TRENDS IN MOLECULAR MEDICINE (2011)
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome
M. G. Narducci et al.
CELL DEATH & DISEASE (2011)
Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype
I. Van der Auwera et al.
BRITISH JOURNAL OF CANCER (2010)
Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Marco Ragusa et al.
MOLECULAR CANCER THERAPEUTICS (2010)
ATM is down-regulated by N-Myc-regulated microRNA-421
Hailiang Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Systematic validation of predicted microRNAs for cyclin D1
Qiong Jiang et al.
BMC CANCER (2009)
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
Biyun Qian et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
Rebecca J. Webster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular targets for treatment of inflammatory breast cancer
Hideko Yamauchi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
INNOVATION Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
Brian D. Brown et al.
NATURE REVIEWS GENETICS (2009)
Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
Roy Navon et al.
PLOS ONE (2009)
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
Aoife J. Lowery et al.
BREAST CANCER RESEARCH (2009)
NF-kappa B genes have a major role in Inflammatory Breast Cancer
Florence Lerebours et al.
BMC CANCER (2008)
Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer
Steven Van Laere et al.
CLINICAL CANCER RESEARCH (2008)
Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
Elisabetta Ferretti et al.
EMBO JOURNAL (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Switching from repression to activation: MicroRNAs can up-regulate translation
Shobha Vasudevan et al.
SCIENCE (2007)
Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis
S. Van Laere et al.
BRITISH JOURNAL OF CANCER (2007)
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
N. Cabioglu et al.
ANNALS OF ONCOLOGY (2007)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
Trends for inflammatory breast cancer: Is survival improving?
Ana M. Gonzalez-Angulo et al.
ONCOLOGIST (2007)
Molecular heterogeneity of inflammatory breast cancer: A hyperproliferative phenotype
Dang M. Nguyen et al.
CLINICAL CANCER RESEARCH (2006)
Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy
HK Dressman et al.
CLINICAL CANCER RESEARCH (2006)
Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis
S Van Laere et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast
CG Kleer et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer
F Bertucci et al.
CANCER RESEARCH (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'
E Charafe-Jaufrret et al.
JOURNAL OF PATHOLOGY (2004)
Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification
I Van der Auwera et al.
CLINICAL CANCER RESEARCH (2004)
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy
F Bertucci et al.
CANCER RESEARCH (2004)
Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature
I Bièche et al.
CLINICAL CANCER RESEARCH (2004)
Vasculogenic mimicry and pseudo-comedo formation in breast cancer
K Shirakawa et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
